/
/
/

Asston Pharmaceuticals Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%

Share Price Live Stats

Open (₹)105.05
Volume (₹)21,000.00
High (₹)107.80
Upper Circuit110.90
Low (₹)101.00
Lower Circuit100.40
Prev Close105.65
52W High (₹)126.10
Price107.80
52W Low (₹)60.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)89.93 Cr
Div. Yield (%)0.00
PE Ratio23.27
Debt to Equity0.68
Price to Book0.00
Book Value17.09
EPS (TTM)4.54
Face Value10.00
ROE (%)50.56

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
ZYDUSLIFE-ANSE
CIPLA-ANSE
LAURUSLABS-ANSE
LUPIN-ANSE
MANKIND-ANSE
DRREDDY-ANSE
AUROPHARMA-ANSE
APL-MTNSE
LTP
1W Low
1W High
Market cap (₹)
1900-20.1 (-1.05%)
1896.30
1964.85
4,56,833Cr
9149.95-119.05 (-1.28%)
9051.85
9296
2,45,426Cr
4825.8-209.2 (-4.15%)
4822.25
5049
1,87,320Cr
1127.5-59.5 (-5.01%)
1126
1191.45
1,13,217Cr
1379.1-38.9 (-2.74%)
1376
1426.20
1,12,212Cr
1846.4-88.9 (-4.59%)
1812
1947.90
1,01,155Cr
2110.85-64.15 (-2.95%)
2107.35
2209
97,626Cr
2333.1-54.3 (-2.27%)
2323.15
2407.40
96,859Cr
1157.3-20.5 (-1.74%)
1155
1179.90
96,406Cr
1650+0 (0.00%)
1623.05
1706.70
93,614Cr
107.8-8.1 (-6.99%)
101
126.10
90Cr

Key Highlights of Asston Pharmaceuticals Ltd’s P&L

In 2025-03-31, Asston Pharmaceuticals Ltd reported total revenue of ₹25.04Cr, compared with ₹15.59Cr in 2024-03-31, reflecting Asston Pharmaceuticals Ltd turnover.

Depreciation was ₹8.1Lakh and finance costs were ₹94.97Lakh in 2025-03-31

Profit Before Tax (PBT) has been ₹5.7Cr in 2025-03-31 as compared to ₹1.82Cr in 2024-03-31.

Net Profit (PAT) was ₹4.33Cr in 2025-03-31 compared with ₹1.36Cr in 2024-03-31.

Earnings per share (EPS) were ₹6.90 in 2025-03-31, compared with ₹17.35 in 2024-03-31.